about
Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patientsChinese SLE treatment and research group registry: III. association of autoantibodies with clinical manifestations in Chinese patients with systemic lupus erythematosus.Repositioning antimicrobial agent pentamidine as a disruptor of the lateral interactions of transmembrane domain 5 of EBV latent membrane protein 1.Associations between TNF-α-308A/G polymorphism and susceptibility with dermatomyositis: a meta-analysis.Therapeutic Developments Targeting Toll-like Receptor-4-Mediated NeuroinflammationTargeting the lateral interactions of transmembrane domain 5 of Epstein-Barr virus latent membrane protein 1Clinical analysis of 56 patients with rhupus syndrome: manifestations and comparisons with systemic lupus erythematosus: a retrospective case-control study.Toll-like receptors as therapeutic targets for autoimmune connective tissue diseasesRifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain.Development of Antibacterial Drugs by Targeting Toll-Like Receptors.A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23
P50
Q33414047-0D792F83-FC75-4309-AF47-3A09E2EFD12BQ33597476-1217F27A-5F53-42C3-9D10-EC819277F365Q34456483-A425E502-7543-437E-B47F-97F80AB1EBE7Q35220862-14397A97-F1B4-47AF-843F-B491F27F26F9Q35681383-B2AB194C-CA53-4F8C-B342-444D96E1971DQ36044463-8E630486-1136-4539-A210-12E7033C08ABQ36193606-2B676DF6-95F1-4E4B-A526-7D722502AB79Q36940639-BE63D3A6-57A8-4D48-8C5E-74B01F9FAA03Q36945155-8C68876A-7E1D-4E20-AD30-11B05FB4B098Q38939907-5C5147AF-E7EE-4642-9896-08F47AFDBF2AQ57603213-3AE5BC14-A9DA-4864-AC58-3679D104F59C
P50
description
researcher ORCID: 0000-0003-2504-1629
@en
name
Jing Li
@ast
Jing Li
@en
Jing Li
@nl
Jing Li
@sl
type
label
Jing Li
@ast
Jing Li
@en
Jing Li
@nl
Jing Li
@sl
prefLabel
Jing Li
@ast
Jing Li
@en
Jing Li
@nl
Jing Li
@sl
P106
P31
P496
0000-0003-2504-1629